ahlam1399
06-10-2015, 10:18 AM
**vartis says study shows secukinumab works in spinal inflammation condition
ZURICH (Reuters) - **vartis AG said one-year results of its drug secukinumab show it is effective in treating patients with ankylosing spondylitis (AS), a debilitating joint condition of the spine.http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4718b1e8/sc/14/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/rc/1/rc.img (http://da.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/rc/1/rc.htm)
http://da.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/rc/2/rc.img (http://da.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/rc/2/rc.htm)
http://da.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/rc/3/rc.img (http://da.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/a2.img (http://da.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/ach.img (http://adchoice.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/ach.htm)http://pi.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/a2t.imghttp://pi2.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=g8-uxO8UaoQ:W5FUPDW8hfY:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=g8-uxO8UaoQ:W5FUPDW8hfY:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=g8-uxO8UaoQ:W5FUPDW8hfY:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=g8-uxO8UaoQ:W5FUPDW8hfY:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=g8-uxO8UaoQ:W5FUPDW8hfY:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/g8-uxO8UaoQ
ZURICH (Reuters) - **vartis AG said one-year results of its drug secukinumab show it is effective in treating patients with ankylosing spondylitis (AS), a debilitating joint condition of the spine.http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4718b1e8/sc/14/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/rc/1/rc.img (http://da.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/rc/1/rc.htm)
http://da.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/rc/2/rc.img (http://da.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/rc/2/rc.htm)
http://da.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/rc/3/rc.img (http://da.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/a2.img (http://da.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/ach.img (http://adchoice.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/ach.htm)http://pi.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/a2t.imghttp://pi2.feedsportal.com/r/231041594672/u/49/f/654207/c/35217/s/4718b1e8/sc/14/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=g8-uxO8UaoQ:W5FUPDW8hfY:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=g8-uxO8UaoQ:W5FUPDW8hfY:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=g8-uxO8UaoQ:W5FUPDW8hfY:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=g8-uxO8UaoQ:W5FUPDW8hfY:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=g8-uxO8UaoQ:W5FUPDW8hfY:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/g8-uxO8UaoQ